Human TIGIT Antibody
R&D Systems, part of Bio-Techne | Catalog # MAB78981
Scientific images may be resized, cropped, or adjusted for brightness or contrast for presentation purposes. These updates are limited to presentation and do not affect the underlying scientific interpretation of the data. Where available, additional source data may be provided upon request.
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Blockade of Receptor-ligand Interaction
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG1 Clone # 741170
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human TIGIT
Met1-Pro141
Accession # Q495A1
Met1-Pro141
Accession # Q495A1
Specificity
Detects human TIGIT in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Scientific Data Images for Human TIGIT Antibody
Detection of TIGIT by Flow Cytometry
DNAM-1 Blockade Attenuates and TIGIT Blockade Augments NK-Mediated Cytotoxicity against Adenovirus-Infected CellsThe changes of NK receptors on pNK after exposure to adenovirus-infected TOV21G or their conditioned media were evaluated by flow cytometry. (A) Summary analyses of independent experiments (n = 5) for DNAM-1 (left) and TIGIT (right) expression. (B) Representative images of DNAM-1 (left) and TIGIT (right) expression (Mann-Whitney U tests; CC, co-culture; CM, conditioned-medium). pNK were co-cultured with dl922-947-infected cells with or without a blocking anti-DNAM-1 antibody (10 μg/mL) and assessed by time-lapse microscopy. (C) Representative data of fluorescent object counts over time for TOV21G (left) and summary data (n = 5) of TAUC for TOV21G (right) and (D) OVCAR4 (n = 3) are shown (one-way ANOVA with multiple comparisons test). (E) pNK were co-cultured with OV-infected TOV21G cells with or without a blocking anti-TIGIT antibody (20 μg/mL) and assessed by time-lapse microscopy (n = 5, each line represents a unique donor; also see Figure S8). Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/32195317), licensed under a CC-BY license. Not internally tested by R&D Systems.Applications for Human TIGIT Antibody
Application
Recommended Usage
Reviewed Applications
Read 1 review rated 4 using MAB78981 in the following applications:
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Reconstitution
Reconstitute at 0.5 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Shipping
Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: TIGIT
Long Name
T Cell Immunoreceptor with Ig and ITIM Domains
Alternate Names
VSIG9, VSTM3, WUCAM
Gene Symbol
TIGIT
UniProt
Additional TIGIT Products
Product Documents for Human TIGIT Antibody
Product Specific Notices for Human TIGIT Antibody
For research use only
Loading...
Loading...
Loading...
Loading...